Aktienanalyse zu Senestech Inc (SNES)SNESSenestech Inc

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption. It operates in the Basic Materials sector (AGRICULTURAL CHEMICALS industry).

Senestech Inc is not a good buy right now due to its current price of $1.08, which reflects a staggering year-to-date change of -51.13% and a one-year change of -78.40%. The RSI is extremely low at 17.651, indicating oversold conditions, but the overall financial health remains concerning with a net loss of $1.83 million in Q2 2026 and a forward P/E of 3.399, suggesting potential undervaluation but also significant risk.

2 analysts cover SNES: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 10.00.